ArticleRheumatology (Oxford, England)2025

Long-term efficacy of MAS825, a bispecific anti-IL1β and IL-18 monoclonal antibody, in two patients with systemic JIA and recurrent episodes of macrophage activation syndrome.

Roberta Caorsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.